GENETICALLY ENGINEERED DOUBLE NEGATIVE T CELLS AS AN ADOPTIVE CELLULAR THERAPY Application EP-4069831-A4 European Patent Office 28 Feb 2024
METHOD FOR EFFICIENTLY AND STABLY TRANSDUCING ANTIGEN CHIMERIC RECEPTOR DOUBLE-NEGATIVE T… Application WO-2023078425-A1 World Intellectual Property Organisation (WIPO) 11 May 2023
GENETICALLY ENGINEERED DOUBLE NEGATIVE T CELLS AS AN ADOPTIVE CELLULAR THERAPY Application WO-2021108926-A1 World Intellectual Property Organisation (WIPO) 10 Jun 2021